Filing Details

Accession Number:
0000849146-20-000029
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-15 15:56:46
Reporting Period:
2020-01-15
Accepted Time:
2020-01-15 15:56:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849146 Lifevantage Corp LFVN Pharmaceutical Preparations (2834) 841097796
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642848 Jay Darren Jensen 9785 South Monroe Street, Suite 400
Sandy UT 84070
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-15 4,500 $15.48 507,032 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2019.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.47 to $15.56, inclusive.The reporting person undertakes to provide to LifeVantage Corporation, any security holder of LifeVantage Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.